KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Operating Expenses (2016 - 2025)

National Health Investors (NHI) has disclosed Operating Expenses for 17 consecutive years, with $69.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 28.79% year-over-year to $69.8 million, compared with a TTM value of $239.0 million through Dec 2025, up 12.78%, and an annual FY2025 reading of $239.0 million, up 12.78% over the prior year.
  • Operating Expenses was $69.8 million for Q4 2025 at National Health Investors, up from $57.6 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $69.8 million in Q4 2025 and bottomed at $40.7 million in Q2 2021.
  • Average Operating Expenses over 5 years is $55.5 million, with a median of $54.5 million recorded in 2024.
  • The sharpest move saw Operating Expenses surged 74.96% in 2021, then dropped 28.34% in 2023.
  • Year by year, Operating Expenses stood at $68.9 million in 2021, then rose by 0.37% to $69.1 million in 2022, then decreased by 28.34% to $49.5 million in 2023, then rose by 9.42% to $54.2 million in 2024, then grew by 28.79% to $69.8 million in 2025.
  • Business Quant data shows Operating Expenses for NHI at $69.8 million in Q4 2025, $57.6 million in Q3 2025, and $55.6 million in Q2 2025.